Kyle Kathryn W

Kyle Kathryn W serves as the Executive Vice President at Labcorp Holdings Inc., a leading healthcare company. This profile details her SEC Form 4 disclosures from February 10, 2026, to July 6, 2026, highlighting her sale activity within the organization. Over this period, she has reported a total of 14 disclosures, exclusively involving the healthcare sector, with reported sale amounts ranging from $26.3K to $201.1K, including a significant transaction valued at $768.1K on February 12, 2026.